Novo's Wegovy pill tracks 3,071 prescriptions in first days of launch
Tweet
Share
E-mail
FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, December 3, 2025. REUTERS/Tom Little/File Photo
LONDON, Jan 16 (Reuters) - Novo Nordisk's Wegovy pill hit 3,071 U.S. prescriptions in the first four days after its launch, IQVIA data shared by analysts on Friday showed, as investors closely watch to see if the firm can ram home its first-mover advantage against rival Eli Lilly in a competitive weight-loss market.
The data reflects retail prescriptions for oral Wegovy, not those filled through the drugmaker's online NovoCare Pharmacy, so actual prescription numbers will be higher, Barclays analysts said in a note.
(Reporting by Bhanvi Satija; Editing by Joe Bavier)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- S&P Global Ratings warns of risks from China's generous credit ratings
- Lula adopts cautious Brazil election campaign, sources say
- Explainer-How will the result of the Saxony-Anhalt election be decided?
Create E-mail Alert Related Categories
ReutersRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
